SEC Comment Letter for Translate Bio, Inc. (CIK 0001693415) — Mar 19, 2020
Translate Bio, Inc. (CIK 0001693415)
Date: March 19, 2020 · CIK: 0001693415 · Accession: 0000000000-20-002440
AI Filing Summary & Sentiment
File numbers found in text: 333-237159
Letter
March 19, 2020 Ronald C. Renaud, Jr. President and Chief Executive Officer Translate Bio, Inc. 29 Hartwell Avenue Lexington, MA 02421 Re:Translate Bio, Inc. Registration Statement on Form S-3 Filed March 13, 2020 File No. 333-237159 Dear Mr. Renaud: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Christine Westbrook at 202-551-5019 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Cynthia Mazareas, Esq.
Show Raw Text
March 19, 2020
Ronald C. Renaud, Jr.
President and Chief Executive Officer
Translate Bio, Inc.
29 Hartwell Avenue
Lexington, MA 02421
Re:Translate Bio, Inc.
Registration Statement on Form S-3
Filed March 13, 2020
File No. 333-237159
Dear Mr. Renaud:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Christine Westbrook at 202-551-5019 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Cynthia Mazareas, Esq.